Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Reata Pharmaceuticals Inc (RETA)  
$172.36 0.00 (0.00%) as of 4:30 Mon 9/25


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 31,730,000
Market Cap: 5.47(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $90.01 - $172.36
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Reata Pharmaceuticals is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapies. Co. focuses on therapeutics for the treatment of diseases with few or no approved therapies. Co.'s main programs are in rare forms of chronic kidney disease (CKD) and a rare neurological disease. Co.'s primary product candidates include bardoxolone methyl (bardoxolone) in patients with CKD caused by Alport syndrome and omaveloxolone in patients with a neurological disorder called Friedreich's ataxia. Both bardoxolone and omaveloxolone activate the transcription factor Nrf2 to normalize mitochondrial function, restore redox balance, and resolve inflammation.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 139,124 598,993
Total Sell Value $0 $0 $22,953,536 $63,982,389
Total People Sold 0 0 8 10
Total Sell Transactions 0 0 15 53
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 393
  Page 13 of 16  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Novo A/s 10% Owner   –       –       •   2017-06-07 4 S $28.04 $56,079 D/D (2,000) 876,297     -
   Novo A/s 10% Owner   –       –       •   2017-06-06 4 S $28.09 $1,802,490 D/D (64,170) 878,297     -
   Novo A/s 10% Owner   –       –       •   2017-06-05 4 S $28.67 $668,825 D/D (23,327) 942,467     -
   Abbvie Inc. 10% Owner   –       –       •   2017-03-28 4 S $22.50 $10,125,000 D/D (450,000) 1,190,473     -
   Abbvie Inc. 10% Owner   –       –       •   2017-02-02 4 A $0.00 $0 D/D 1,505,241 1,640,473     -
   Bass James Edward Director   –       •      –    2017-01-05 4 A $0.00 $0 I/I 54,554 17,555     -
   Bass James Edward Director   –       •      –    2017-01-05 4 A $0.00 $0 D/D 28,762 59,347     -
   Cpmg Inc   •       •       •   2016-12-30 4 B $21.72 $204,038 I/I 9,392 334,740 2.64     -
   Mcgaughy R Kent Jr   •       •       •   2016-12-30 4 B $21.72 $204,038 I/I 9,392 1,926,034 2.64     -
   Traweek James W Jr   •       •       •   2016-12-30 4 B $21.72 $204,038 I/I 9,392 1,926,034 0.01     -
   Estate Of Edward W. Rose Iii Member of a 10% owner group   –       –       •   2016-12-29 4 GD $0.00 $0 I/I 100,985 67,735     -
   Estate Of Edward W. Rose Iii Member of a 10% owner group   –       –       •   2016-12-29 4 A $0.00 $0 D/D 12,091 13,517     -
   Estate Of Edward W. Rose Iii Member of a 10% owner group   –       –       •   2016-12-29 4 A $0.00 $0 I/I 37,909 180,909     -
   Estate Of Edward W. Rose Iii Member of a 10% owner group   –       –       •   2016-12-29 4 D $0.00 $0 I/I (145,454) 811,546     -
   Mcgaughy R Kent Jr   •       •       •   2016-12-16 4 B $22.99 $3,787,820 I/I 164,753 1,916,642 2.64     -
   Traweek James W Jr   •       •       •   2016-12-16 4 B $22.99 $3,787,820 I/I 164,753 1,916,642 0.01     -
   Cpmg Inc   •       •       •   2016-12-16 4 B $22.99 $3,787,820 I/I 164,753 332,230 0.01     -
   Mcgaughy R Kent Jr   •       •       •   2016-12-15 4 B $22.05 $59,534 I/I 2,700 1,751,889 2.64     -
   Traweek James W Jr   •       •       •   2016-12-15 4 B $22.05 $59,534 I/I 2,700 1,751,889 2.64     -
   Cpmg Inc   •       •       •   2016-12-15 4 B $22.05 $59,534 I/I 2,700 290,120 2.64     -
   Mcgaughy R Kent Jr   •       •       •   2016-12-14 4 B $21.37 $132,229 I/I 6,189 1,749,189 2.64     -
   Traweek James W Jr   •       •       •   2016-12-14 4 B $21.37 $132,229 I/I 6,189 1,749,189 2.64     -
   Cpmg Inc   •       •       •   2016-12-14 4 B $21.37 $132,229 I/I 6,189 289,541 2.64     -
   Bass James Edward Director   –       •      –    2016-12-14 4 B $21.76 $108,800 D/D 5,000 30,585 2.39     -
   Abbvie Inc. 10% Owner   –       –       •   2016-09-23 3 IO $0.00 $0 D/D 0 135,232     -
  393 Records found
  Previous  10  11  12  13  14  15  16   
  Page 13 of 16
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us